These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28826422)

  • 21. Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection.
    Duncan JR; Witkop CT; Webber BJ; Costello AA
    Vaccine; 2017 Apr; 35(18):2351-2357. PubMed ID: 28359621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Epidemiology of Herpes Zoster After Varicella Immunization Under Different Biological Hypotheses: Perspectives From Mathematical Modeling.
    Guzzetta G; Poletti P; Merler S; Manfredi P
    Am J Epidemiol; 2016 Apr; 183(8):765-73. PubMed ID: 26994062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic burden of varicella in Europe in the absence of universal varicella vaccination.
    Pawaskar M; Méroc E; Samant S; Flem E; Bencina G; Riera-Montes M; Heininger U
    BMC Public Health; 2021 Dec; 21(1):2312. PubMed ID: 34930179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.
    van Lier A; Lugnér A; Opstelten W; Jochemsen P; Wallinga J; Schellevis F; Sanders E; de Melker H; van Boven M
    EBioMedicine; 2015 Oct; 2(10):1494-9. PubMed ID: 26629544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Varicella in Americans from NHANES III: implications for control through routine immunization.
    Kilgore PE; Kruszon-Moran D; Seward JF; Jumaan A; Van Loon FP; Forghani B; McQuillan GM; Wharton M; Fehrs LJ; Cossen CK; Hadler SC
    J Med Virol; 2003; 70 Suppl 1():S111-8. PubMed ID: 12627498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Varicella zoster virus infection occurs at a relatively young age in The Netherlands.
    van Lier A; Smits G; Mollema L; Waaijenborg S; Berbers G; van der Klis F; Boot H; Wallinga J; de Melker H
    Vaccine; 2013 Oct; 31(44):5127-33. PubMed ID: 23973248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Burden of varicella in the Asia-Pacific region: a systematic literature review.
    Goh AEN; Choi EH; Chokephaibulkit K; Choudhury J; Kuter B; Lee PI; Marshall H; Kim JO; Wolfson LJ
    Expert Rev Vaccines; 2019 May; 18(5):475-493. PubMed ID: 30869552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.
    Wiese-Posselt M; Siedler A; Mankertz A; Sauerbrei A; Hengel H; Wichmann O; Poethko-Müller C
    BMC Infect Dis; 2017 May; 17(1):356. PubMed ID: 28525973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vaccines against varicella-zoster virus (VZV)].
    Salleras L; Salleras M; Soldevila N; Prat A; Garrido P; Domínguez Á
    Enferm Infecc Microbiol Clin; 2015; 33(6):411-23. PubMed ID: 26096575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of pediatric herpes zoster after varicella infection: a population-based study.
    Wen SY; Liu WL
    Pediatrics; 2015 Mar; 135(3):e565-71. PubMed ID: 25713285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is Europe ready to embrace a policy of universal varicella vaccination?
    Ramet J; Weil-Olivier C; Sedlak W;
    Int J Clin Pract; 2005 Nov; 59(11):1326-33. PubMed ID: 16236088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Varicella seroprevalence in Turkish population in Cyprus.
    Kurugol Z; Koturoglu G; Aksit S; Ozacar T
    Acta Paediatr; 2007 Jun; 96(6):861-3. PubMed ID: 17465984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Varicella vaccination: a laboured take-off.
    Carrillo-Santisteve P; Lopalco PL
    Clin Microbiol Infect; 2014 May; 20 Suppl 5():86-91. PubMed ID: 24494784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Varicella seroprevalence in healthcare workers in a tertiary hospital: an audit of cross-sectional data.
    Gorny AW; Mittal C; Saw S; Venkatachalam I; Fisher DA; Tambyah PA
    BMC Res Notes; 2015 Nov; 8():664. PubMed ID: 26555677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validity of reported varicella history as a marker for varicella zoster virus immunity among unvaccinated children, adolescents, and young adults in the post-vaccine licensure era.
    Perella D; Fiks AG; Jumaan A; Robinson D; Gargiullo P; Pletcher J; Forke CM; Schmid DS; Renwick M; Mankodi F; Watson B; Spain CV
    Pediatrics; 2009 May; 123(5):e820-8. PubMed ID: 19403475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix.
    Ouwens MJ; Littlewood KJ; Sauboin C; Téhard B; Denis F; Boëlle PY; Alain S
    Clin Ther; 2015 Apr; 37(4):816-829.e10. PubMed ID: 25726457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The epidemiology of Varicella Zoster Virus infection in Italy.
    Gabutti G; Rota MC; Guido M; De Donno A; Bella A; Ciofi degli Atti ML; Crovari P;
    BMC Public Health; 2008 Oct; 8():372. PubMed ID: 18954432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence and social determinants of varicella in Turkey.
    Hekimoğlu CH; Özbek ÖA; Emek M; Öktem MA; Köroğlu G; Sertel M; Özdeniz S; Ceylan A; Açikgöz A; Ünal B
    East Mediterr Health J; 2018 Jun; 24(3):295-301. PubMed ID: 29908025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical and economic burden of varicella in the Middle East: a systematic literature review.
    Al Kaabi N; Al Olama FMAS; Al Qaseer M; Al Ubaidani I; Dinleyici EC; Hayajneh WA; Bizri AR; Loulou M; Ndao T; Wolfson LJ
    Hum Vaccin Immunother; 2020; 16(1):21-32. PubMed ID: 31373864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group?
    Alfonsi V; Montomoli E; Manini I; Alberini I; Gentile C; Rota MC; Ciofi degli Atti ML
    Vaccine; 2007 Aug; 25(32):6086-8. PubMed ID: 17629374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.